Parvovirus B19, Molecular Detection, Quantitative, Amniotic Fluid Build info

Synonyms

• PARVOVIRUS B19 PCR, AF
• PARVOPCRAM
• PARVOVIRUS B19 PCR, AF
• Fifth disease
• Erythema Infectiosum
• LAB11215

Short Name

PARVOVIRUS B19 PCR, AF

Procedure Master Number

LAB11215

Procedure ID

114806

Clinical Info

Parvovirus B19 manifests itself as an acute or chronic hematological disorde
r in immunocompromised patients. It can cause persistent anemia, sometimes
associated with leukopenia and thrombocytopenia. Pediatric transplant patients
are at risk for chronic infections, which can be associated with lung and/or renal
disorders. Quantitative DNA PCR can be used to detect the presence of the
virus, track the course of infection, and monitor response to treatment.

Specimen Type

Body Fluid

Container

Sterile

Collection Instructions

Container/Tube;: Sterile Screw Top Tubes
Specimen: 2 mL amniotic Fluid (0.5 mL min)
Transport Temperature: Room Temperature

Transport Instructions

Specimen Stability

4 Days Room Temperature

Methodology

Real-Time PCR Quantitative

Days Performed

TAT; 2 - 3 Days

Performing Laboratory

Viracor-Eurofins

CPT

87799

PDM

225036

Results